You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

estrogen receptor-beta

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Denver, Sarasota, Nashville (AC682)

Recruiting
  • Breast Cancer
  • Denver, Colorado
  • +4 more
Dec 12, 2022

Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (drug, other, biological)

Suspended
  • Metastatic Breast Carcinoma
  • Stage IV Breast Cancer AJCC v6 and v7
  • Corona, California
  • +6 more
Sep 28, 2022

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Metastatic Breast Cancer Trial in Belgium, Netherlands (RAD1901)

Completed
  • Metastatic Breast Cancer
  • Bruxelles, Belgium
  • +4 more
Aug 16, 2022

Breast Cancer Female Trial in Belgium (Palbociclib)

Completed
  • Breast Cancer Female
  • Anderlecht, Belgium
  • +4 more
Jun 23, 2022

Estrogen Receptor Positive Breast Cancer, Breast Tumor, Metastatic Breast Cancer Trial in Philadelphia ([18F]FES)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jul 5, 2022

Breast Cancer Trial in Philadelphia (BPET/DBT imaging, 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Dec 12, 2022

Breast Cancer Trial in Shanghai (ARV-471)

Not yet recruiting
  • Breast Cancer
  • Shanghai, China
    Cancer Hospital Chinese Academy of Medical Sciences
Feb 7, 2023

Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +3 more
Apr 15, 2022

Hormone Receptor-positive Breast Cancer Trial (LACUDY)

Not yet recruiting
  • Hormone Receptor-positive Breast Cancer
  • (no location specified)
Dec 6, 2022

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +6 more
  • Baltimore, Maryland
    University of Maryland Baltimore
Apr 29, 2022

Endometrial Tissues and Mononuclear Cells Receptivity in

Completed
  • Endometrial Hyperplasia Without Atypia
  • +6 more
  • endometrial tissue and peripheral blood mononuclear cells receptivity
  • (no location specified)
Oct 29, 2023

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Breast Cancer, Estrogen Receptor-positive Breast Cancer Trial in Charlottesville (Aspirin, Tamoxifen Pill, Doxorubicin)

Withdrawn
  • Breast Cancer
  • Estrogen Receptor-positive Breast Cancer
  • Charlottesville, Virginia
    University of Virginia
Nov 12, 2021

Diabetes Trial in Vienna, Paris (68Ga-NODAGA-exendin-4 PET/CT)

Recruiting
  • Diabetes Mellitus
  • 68Ga-NODAGA-exendin-4 PET/CT
  • Vienna, Austria
  • +1 more
Jun 16, 2022

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and

Not yet recruiting
  • HER2+ Advanced Breast Cancer
  • Other Solid Tumors
  • ADCC-R-Epo-R T-cells + Trastuzumab
  • +2 more
  • (no location specified)
Aug 31, 2023

Obesity, Prediabetes Trial in La Jolla (Mirabegron)

Not yet recruiting
  • Obesity, Prediabetes
  • La Jolla, California
    UC San Diego Altman Clinical & Translational Research Institute
Nov 21, 2022

Breast Cancer Trial in New York (core needle biopsy, blood draw)

Recruiting
  • Breast Cancer
  • core needle biopsy
  • blood draw
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 9, 2023

Breast Tumors Trial in Wuhu Shi, Changsha, Shanghai (LY3484356)

Not yet recruiting
  • Breast Neoplasms
  • Wuhu Shi, Anhui, China
  • +2 more
Aug 19, 2022

Estrogen Receptor Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in Seattle (procedure, drug,

Terminated
Has Results
  • Estrogen Receptor Positive
  • +2 more
  • Computed Tomography
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 28, 2021

Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

Active, not recruiting
  • Breast Neoplasms
  • +7 more
  • Goodyear, Arizona
  • +38 more
Jun 29, 2022

Blood and Tumor Samples From Advanced or Metastatic Estrogen

Active, not recruiting
  • Advanced Breast Carcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Active, not recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023